JP Morgan Chase
GH icon

JP Morgan Chase’s Guardant Health GH Stock Holding History

JP Morgan Chase’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,700
Closed -$998K – 6897
2022
Q4 		$998K Sell
36,700
-3,900
-10% -$178K ﹤0.01% 4037
2022
Q3 		$2.19M Buy
+40,600
New +$2.08M ﹤0.01% 3393
2019
Q2 		– Sell
-10,200
Closed -$782K – 5842
2019
Q1 		$782K Buy
+10,200
New +$565K ﹤0.01% 3953

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's GH Position: Q1 2026 in Review

JP Morgan Chase increased its Guardant Health (GH) stake by 12% in Q1 2026, buying an estimated $3.34M and bringing the position to 304,317 shares worth $26.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

JP Morgan Chase first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $126M in Q3 2019. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • JP Morgan Chase held 304,317 shares of Guardant Health worth $26.2M as of Q1 2026.
  • JP Morgan Chase bought 33,278 Guardant Health shares in Q1 2026, an estimated $3.34M.
  • Guardant Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1856 holding.
  • JP Morgan Chase first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • JP Morgan Chase's Guardant Health position peaked at $126M in Q3 2019.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.